Cancer researchers highlighted several treatment breakthroughs during their annual summit in Chicago that concluded Tuesday, ...
"One of the most amazing things I’ve ever seen," clinician-scientist Samuel Hume wrote alongside a video clip posted on X.
A Penn Medicine study found that women taking GLP‑1 drugs such as Wegovy had a slightly lower rate of breast cancer diagnoses ...
Findings from a study of Veracyte’s Prosigna genomic assay and GRAIL’s multi-cancer early detection test were presented at ...
For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with ...
GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week ...
GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results